Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles Prince

Showing results (61-70 of 318) with videos related to

Pageof 32
Sort By:
Journal of Personalized Medicine|June 2, 2021
Targeted Approaches to T-Cell LymphomaSean Harrop, Chathuri Abeyakoon, Carrie Van Der Weyden, et al.
Leukemia & Lymphoma|May 5, 2021
Management of hydroxyurea resistant or intolerant polycythemia veraIndu Raman, Sant-Rayn Pasricha, H Miles Prince, et al.
Journal of Blood Medicine|August 19, 2016
Update and new approaches in the treatment of Castleman diseaseKah-Lok Chan, Stephen Lade, H Miles Prince, et al.
The FEBS Journal|April 27, 2016
How do tumor cells respond to HDAC inhibition?Andrea Newbold, Katrina J Falkenberg, H Miles Prince, et al.
The Australasian Journal of Dermatology|October 22, 2014
Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two casesKate M Newland, Christopher J McCormack, H Miles Prince, et al.
Scandinavian Journal of Gastroenterology|January 29, 2017
Rituximab-induced Crohn's diseasePoornima Varma, Julianne Falconer, Ahmad Aga, et al.
Orbit (Amsterdam, Netherlands)|September 8, 2021
IgG4-related ophthalmic disease in association with adult-onset asthma and periocular xanthogranuloma: a case reportBrigitte M Papa, H Miles Prince, Alan A McNab, et al.
Leukemia & Lymphoma|June 10, 2015
Prevention of thromboembolism in myeloma: expanding the tool-box of assays to predict the risk?Kate L Burbury, Michael Dickinson, David A Westerman, et al.
Annals of Hematology|September 29, 2004
Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management optionsDirk Hönemann, H Miles Prince, Rodney J Hicks, et al.
Expert Review of Anticancer Therapy|October 20, 2007
Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agentsMark Bishton, Melita Kenealy, Ricky Johnstone, et al.
Pageof 32

Showing results (61-70 of 318) with videos related to

Sort By:
Pageof 32
Journal of Personalized Medicine|June 2, 2021
Targeted Approaches to T-Cell LymphomaSean Harrop, Chathuri Abeyakoon, Carrie Van Der Weyden, et al.
Leukemia & Lymphoma|May 5, 2021
Management of hydroxyurea resistant or intolerant polycythemia veraIndu Raman, Sant-Rayn Pasricha, H Miles Prince, et al.
Journal of Blood Medicine|August 19, 2016
Update and new approaches in the treatment of Castleman diseaseKah-Lok Chan, Stephen Lade, H Miles Prince, et al.
The FEBS Journal|April 27, 2016
How do tumor cells respond to HDAC inhibition?Andrea Newbold, Katrina J Falkenberg, H Miles Prince, et al.
The Australasian Journal of Dermatology|October 22, 2014
Cutaneous CD30 positive lymphoproliferative disorders with coexistent epithelial neoplasms: Report of two casesKate M Newland, Christopher J McCormack, H Miles Prince, et al.
Scandinavian Journal of Gastroenterology|January 29, 2017
Rituximab-induced Crohn's diseasePoornima Varma, Julianne Falconer, Ahmad Aga, et al.
Orbit (Amsterdam, Netherlands)|September 8, 2021
IgG4-related ophthalmic disease in association with adult-onset asthma and periocular xanthogranuloma: a case reportBrigitte M Papa, H Miles Prince, Alan A McNab, et al.
Leukemia & Lymphoma|June 10, 2015
Prevention of thromboembolism in myeloma: expanding the tool-box of assays to predict the risk?Kate L Burbury, Michael Dickinson, David A Westerman, et al.
Annals of Hematology|September 29, 2004
Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management optionsDirk Hönemann, H Miles Prince, Rodney J Hicks, et al.
Expert Review of Anticancer Therapy|October 20, 2007
Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agentsMark Bishton, Melita Kenealy, Ricky Johnstone, et al.
Pageof 32